Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-359677 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 21, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
21,284
Total Value
$0.00
P&L
+inf% (+$715,993.76)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Aug 18, 2026 | Grant/Award | 21,284 | $0.00 | $0.00 | 200,374 | Direct | โ | View Details |